KALA BIO, Inc.
KALA
$5.10
$0.050.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.44% | 8.66% | 6.57% | 18.87% | -36.86% |
| Total Depreciation and Amortization | -1.45% | 9.52% | 3.28% | -7.58% | -5.71% |
| Total Amortization of Deferred Charges | -37.79% | -7.14% | 2.22% | 0.96% | 0.00% |
| Total Other Non-Cash Items | 11.00% | -14.57% | 25.39% | -22.61% | -3.56% |
| Change in Net Operating Assets | -348.25% | -20.12% | 162.84% | -0.10% | 6.10% |
| Cash from Operations | -91.91% | 2.69% | 48.72% | 15.02% | -40.90% |
| Capital Expenditure | -- | 23.33% | -150.00% | -176.92% | -85.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 23.33% | -150.00% | -176.92% | -85.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.44% | -27,827.78% | -- | -- | -- |
| Issuance of Common Stock | -99.89% | -- | -- | 71,185.71% | -96.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | 334.50% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -102.03% | 3,792.22% | -101.20% | 77.37% | 232.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -552.70% | 139.62% | -187.34% | 336.62% | 53.23% |